Can Xanthine Oxidase be Targeted for Therapeutic Interventions?
Yes, xanthine oxidase can be targeted for therapeutic interventions. Inhibitors of xanthine oxidase, such as allopurinol and febuxostat, are used to manage conditions like gout and hyperuricemia by reducing uric acid production. These inhibitors also help mitigate oxidative stress, providing beneficial effects in diseases where ROS play a crucial role. Understanding the histological distribution and activity of xanthine oxidase can aid in developing targeted therapies for these conditions.
